October 21st: Biopharma Consortium Breakfast Meeting

Friday, 21 October 2016 8:00 AM - 10:00 AM PST

475 East Grand Ave, Building 42-1D, South San Francisco, CA, 94080, United States

Register Now

Registration

Sale ended

Registration Partial Approval - Free

Enter your discount code

  • Fee
  • Total amount

1. Select Seats

2. Review and Proceed

Friday, 21 October 2016 8:00 AM - 10:00 AM PST

Genentech, 475 East Grand Ave, South San Francisco, CA, 94080, United States.

Approaching the Patient Adherence challenge in an era with higher stakes, digital enablement, and deeper patient understanding

 
Speaker:  Jeff Hewitt, MBA
Date/Time:  Friday, October 21st, 2016, 8:00-10:00 AM, presentation begins at 8:30 sharp
Place:  Genentech, 42-1D in Bldg 42
            475 East Grand Avenue
            South San Francisco 94080
Admission is free, but registration is required by October 18, 2016
 
Speaker Bio:
Jeff Hewitt is a partner in the Health Practice of A.T. Kearney where he focuses upon helping life sciences companies make significant transformations, improve decision-making, and invest strategically.  This includes assisting over a dozen major life sciences companies improve their R&D decision-making and innovation capabilities through major transformations of process, governance, analytics, and culture.  Engagements have included development investment capability building, cross-therapeutic area strategy, pipeline assessments, external assessments of value, and cost-saving clinical trial optimization.
 
Over twenty years he has supported well more than 100 client engagements across a variety of strategic topics such as franchise strategy, drug development, Healthcare Reform, US market pricing strategy, and patient adherence solutions.  He has a B.A. in Economics and English from Amherst College and an M.B.A from Stanford University.  He is based in A.T. Kearney’s San Francisco office.
 
Abstract:
The patient adherence challenge isn’t new.  Healthcare providers, pharmacists, and pharmaceutical companies have been trying to get patients to take their medicines for decades.  However, it’s different today.  Why is it different. Life-saving specialty medicines come with high prices and high expectations, a broad collection of digital enabled tools and technologies are available, and our understanding of why patients don’t adhere has improved significantly.

These changes create the opportunity for the industry to do better.  This talk will address:
  • The changes that suggest the Patient Adherence challenge should be viewed differently today
  • The reasons that patients don’t adhere
  • What we can learn from adherence solutions in the market today
  • A framework for designing adherence solutions
  • An argument for why building this capability is valuable
 
 

Biopharma Consortium

BioPharma Consortium engages, serves and partners with biotech, pharma, medical device, academia, research institutes and special interest or service groups within the life science industry to provide access to a broad and deep network of professionals and career opportunities fueled by leading edge science, medicine and business.

Contact the Organizer View other events

Comments